Adenosine Diphosphate-Induced Platelets Aggregability in Polysomnographically Verified Obstructive Sleep Apnea

被引:12
作者
Alkhiary, Wael [1 ]
Morsy, Nesreen E. [2 ]
Yousef, Aida M. [2 ]
El-Saddik, Amr Mohamed [1 ]
Arram, Eman O. [2 ]
机构
[1] Mansoura Univ, Mansoura Fac Med, Dept Clin Pathol, Mansoura, Egypt
[2] Mansoura Univ, Mansoura Fac Med, Dept Chest Med, Mansoura, Egypt
关键词
adenosine diphosphate; blood platelets; platelet activation; platelet aggregation; sleep apnea; obstructive; thrombosis; POSITIVE AIRWAY PRESSURE; INTERMITTENT HYPOXIA; ACTIVATION; THERAPY; MARKERS; SCALE; STATE;
D O I
10.1177/1076029615600790
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Obstructive sleep apnea syndrome (OSAS) is a risk factor for arterial thrombosis and cardiovascular morbidity. Activated platelets play key roles in the development of atherothrombosis, thus may be involved in these complications of OSAS. Herein, we evaluated the relationship between severity of OSAS and the degree of platelet aggregates as a marker of activated platelets in 64 patients with OSAS. Platelet aggregations were determined by means of optical aggregometry, using adenosine diphosphate (ADP) as an agonist. Compared with the control group, ADP-induced platelet aggregability was increased in patients with total OSAS, severe OSAS, and in mild to moderate OSAS. Moreover, ADP-induced platelet aggregation was correlated with the Epworth sleepiness scale (ESS) in patients with severe OSAS. Obstructive sleep apnea syndrome is associated with enhanced platelets aggregations, which may predispose the cardiovascular sequels. The ESS may be important in predicting platelet activation and thus atherothrombotic complications in those with OSAS.
引用
收藏
页码:360 / 366
页数:7
相关论文
共 39 条
[1]   Impact of Nasal Continuous Positive Airway Pressure Therapy on Markers of Platelet Activation in Patients with Obstructive Sleep Apnea [J].
Akinnusi, Morohunfolu E. ;
Paasch, Linda L. ;
Szarpa, Kristie R. ;
Wallace, Paul K. ;
El Solh, Ali A. .
RESPIRATION, 2009, 77 (01) :25-31
[2]   Impaired circadian variation of platelet activity in patients with sleep apnea [J].
Barcelo, Antonia ;
Pierola, Javier ;
de la Pena, Monica ;
Frontera, Guillem ;
Yanez, Aina ;
Alonso-Fernandez, Alberto ;
Ayllon, Olga ;
Agusti, Alvar G. N. .
SLEEP AND BREATHING, 2012, 16 (02) :355-360
[3]   SPONTANEOUS PLATELET ACTIVATION AND AGGREGATION DURING OBSTRUCTIVE SLEEP-APNEA AND ITS RESPONSE TO THERAPY WITH NASAL CONTINUOUS POSITIVE AIRWAY PRESSURE [J].
BOKINSKY, G ;
MILLER, M ;
AULT, K ;
HUSBAND, P ;
MITCHELL, J .
CHEST, 1995, 108 (03) :625-630
[4]   Plasma Selectins in Patients with Obstructive Sleep Apnea [J].
Cofta, S. ;
Wysocka, E. ;
Dziegielewska-Gesiak, S. ;
Michalak, S. ;
Piorunek, T. ;
Batura-Gabryel, H. ;
Torlinski, L. .
RESPIRATORY REGULATION - THE MOLECULAR APPROACH, 2013, 756 :113-119
[5]   Platelet activation, epinephrine, and blood pressure in obstructive sleep apnea syndrome [J].
Eisensehr, I ;
Ehrenberg, BL ;
Noachtar, S ;
Korbett, K ;
Byrne, A ;
McAuley, A ;
Palabrica, T .
NEUROLOGY, 1998, 51 (01) :188-195
[6]   Oral antiplatelet therapy for atherothrombotic disease: overview of current and emerging treatment options [J].
Fintel, Dan J. .
VASCULAR HEALTH AND RISK MANAGEMENT, 2012, 8 :77-89
[7]   Intermittent hypoxia and vascular function: implications for obstructive sleep apnoea [J].
Foster, Glen E. ;
Poulin, Marc J. ;
Hanly, Patrick J. .
EXPERIMENTAL PHYSIOLOGY, 2007, 92 (01) :51-65
[8]  
Freynhofer MK, 2012, CURR PHARM DESIGN, V18, P5197
[9]   Could the thromboxane A2 pathway be a therapeutic target for the treatment of obstructive sleep apnea-induced atherosclerosis? [J].
Gautier-Veyret, Elodie ;
Van Noolen, Laetitia ;
Levy, Patrick ;
Pepin, Jean Louis ;
Stanke-Labesque, Francoise .
PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2015, 121 :97-104
[10]   In vivo platelet activation is increased during sleep in patients with obstructive sleep apnea syndrome [J].
Geiser, T ;
Buck, F ;
Meyer, BJ ;
Bassetti, C ;
Haeberli, A ;
Gugger, M .
RESPIRATION, 2002, 69 (03) :229-234